Blood tests may predict cancer return after radiation

NCT ID NCT03325036

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study measured immune-related substances in the blood of 60 head and neck cancer patients before and after they received curative radiotherapy. The goal was to see if these markers could help predict whether the cancer would come back or spread. Researchers hope to find better ways to identify patients who need closer monitoring after treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this could help doctors use blood tests to predict which patients are at higher risk of cancer returning after radiotherapy.

What could go wrong

This is a small, completed observational study, not a treatment trial. The findings may not lead to a widely used test or change patient care directly.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEAD AND NECK CANCERS PATIENTS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

head and neck cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • National Taiwan University Hospital

    Taipei, Taiwan